Pancreatic stone protein point-of-care testing can reduce healthcare expenditure in sepsis

BACKGROUND: Sepsis is a life-threatening organ dysfunction in response to infection. Early recognition and rapid treatment are critical to patient outcomes and cost savings, but sepsis is difficult to diagnose because of its non-specific symptoms. Biomarkers such as pancreatic stone protein (PSP) of...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, John E., Dick, Katherine, Cooper, Jacie T., Chami, Nadine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306195/
https://www.ncbi.nlm.nih.gov/pubmed/35867213
http://dx.doi.org/10.1186/s13561-022-00381-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306195/
https://www.ncbi.nlm.nih.gov/pubmed/35867213
http://dx.doi.org/10.1186/s13561-022-00381-z

Ejemplares similares